About Us

Advanced Genomics APAC

Advanced Genomics APAC Co., Ltd. was established in 2023 as a subsidiary of the UK-based Advanced Genomics Ltd., serving as the Asia-Pacific headquarters in Taoyuan, Taiwan. Our mission is to expand access to innovative genomic testing products and deliver cutting-edge diagnostic solutions to healthcare providers throughout the Asia-Pacific region. Together with our parent companies, Nonacus and Informed Genomics, Advanced Genomics APAC leverages global expertise to introduce advanced, non-invasive genetic testing solutions. 

Company Structure

About Nonacus Ltd.

Nonacus, founded in 2015 in Birmingham, UK, is a leader in cancer genomics and non-invasive genetic testing. The company specializes in advanced liquid biopsy platforms that utilize cell-free circulating DNA (cfDNA) to detect, screen, and monitor cancer, enabling early detection. Its GALEAS platform offers a complete workflow for tumor and liquid biopsy analysis, empowering healthcare providers to deliver personalized, data-driven treatments that improve patient outcomes. 

About Informed Genomics Ltd.

Informed Genomics complements Nonacus’ efforts by providing personalized genomics solutions, with a focus on bladder cancer, hereditary cancer, and comprehensive end-to-end next-generation sequencing services. By translating complex genetic data into actionable insights, Informed Genomics enables healthcare providers and patients to make informed decisions regarding treatment options and preventive care. The company plays a crucial role in advancing precision medicine through the integration of bioinformatics and genetic analysis. 

About Advanced Genomics Co., Ltd.

Advanced Genomics APAC is transforming healthcare across Taiwan, Japan, South Korea, Australia, New Zealand, Mainland China, and Southeast Asia by providing hospitals, laboratories, clinics, and patients with cutting-edge diagnostic technologies and technical support. 

Our Philosophy

Advanced Genomics APAC is committed to transforming cancer detection and personalized medicine through precision genomics. We believe in the potential of innovative genomic technologies to revolutionize healthcare by enabling early detection, more effective treatment stratification, and subsequent patient monitoring. Our core values center on driving innovation and ensuring accessibility, equipping healthcare providers and researchers with cutting-edge diagnostic tools that enhance patient care and improve outcomes.  

Our Vision

Our vision is to become a global leader in the cancer genomic industry, pioneering advancements in non-invasive diagnostic tools that transform cancer care. We are committed to expanding our presence across the Asia-Pacific region, particularly in Japan, South Korea, Mainland China, and Southeast Asia, driving innovation and improving healthcare outcomes throughout the region. 

Our Mission 

Our mission is to make non-invasive genetic testing accessible to all, focusing on oncology, by enabling decentralized, cost-effective, and comprehensive cancer detection. Through the use of innovative platforms and next-generation sequencing (NGS) technologies, we aim to improve patient outcomes by facilitating early cancer detection and optimizing treatment management. 

Our Culture and Team

At Advanced Genomics APAC, we foster a culture of innovation, collaboration, and diversity. Our team consists of experts in cancer genomics, biotechnology, and bioinformatics who are passionate about improving patient outcomes through innovative technology. Employees are unified by a shared commitment to driving advancements in genomics, ensuring that our solutions meet the highest standards of precision and reliability. 

Our Partners

Taiwan

Japan

Hong Kong

South Korea

Vietnam

Malaysia

Singapore

Access